Table 2. Patient demographics and tumor characteristics (n=208).
| Characteristics | VPD | L-VPD | p-value | |
|---|---|---|---|---|
| Patients, n/tot, (%) | 158 (76.0) | 50 (24.0) | <0.05 | |
| Age (yr) | 68 (54–78) | 62 (51–74) | 0.7 | |
| Histology | 0.7 | |||
| HGSOC | 130 (82.3) | 40 (80.0) | ||
| Non HGSOC | 28 (17.7) | 10 (20.0) | ||
| FIGO stage | 0.6 | |||
| IIIC | 120 (75.9) | 44 (88.0) | ||
| IV | 38 (24.1) | 6 (12.0) | ||
| u-VPD | 71 (44.9) | 16 (32.0) | 0.1 | |
| i-VPD | 87 (55.1) | 34 (68.0) | ||
| CA-125 U/mL at diagnosis | 819 (129–3,670) | 645 (112–1,187) | <0.05 | |
| CA-125 U/mL at i-VPD | 190 (15–615) | 90 (5–250) | <0.005 | |
| ECOG 0–1 | 48 (30.4) | 31 (62.0) | <0.005 | |
| ECOG 2 | 110 (69.6) | 19 (38.0) | ||
Values are presented as number (%) or mean (range).
CA-125, cancer antigen 125; ECOG, Eastern Cooperative Oncology Group Performance Status Scale; FIGO, International Federation of Gynecology and Obstetrics; HGSOC, high grade serous ovarian cancer; i-VPD, interval visceral-peritoneal debulking; L-VPD, laparoscopic visceral-peritoneal debulking; u-VPD, upfront visceral-peritoneal debulking; VPD, visceral-peritoneal debulking.